XTalks

MARCH 18, 2025

Standard treatment strategies include combinations of antibiotics, hormonal therapies and biologic agents most notably adalimumab (Humira), the only FDA-approved biologic for moderate to severe cases while surgery remains an option for advanced disease.

Trials 59

Trials Clinical Trials Clinical Trials Hormones 59

Pharmaceutical Technology

APRIL 19, 2023

Bayer has announced that it will shift the focus of its drug research away from women’s health to four core therapeutic areas: oncology, cardiovascular, neurology and rare diseases/immunology.

Gene Therapy 130

Gene Therapy Hormones Production Sales 130

Pharmaceutical Technology

MARCH 10, 2023

Pharmaceutical and biotechnology industries widely use freeze-drying systems to protect vaccines, antibodies, antibiotics such as penicillin, blood plasma, proteins, enzymes, hormones, viruses, and bacteria from heat and minimise their biological activity.

Manufacturing 147

Manufacturing Production Containment Antibody 147

Pharmaceutical Technology

JUNE 5, 2023

Rezvilutamide is indicated for the treatment of metastatic hormone sensitive prostate cancer. Jiangsu Hengrui Medicine overview Jiangsu Hengrui Medicine (Jiangsu Hengrui) is a biopharmaceutical company that focuses on the research, development, manufacture, and distribution of novel pharmaceutical products.

Medicine 100

Medicine Hormones Production Clinical Trials 100

Pharmaceutical Technology

JUNE 5, 2023

Rezvilutamide is indicated for the treatment of metastatic hormone sensitive prostate cancer. Jiangsu Hengrui Medicine overview Jiangsu Hengrui Medicine (Jiangsu Hengrui) is a biopharmaceutical company that focuses on the research, development, manufacture, and distribution of novel pharmaceutical products.

Medicine 100

Medicine Hormones Production Clinical Trials 100

pharmaphorum

AUGUST 11, 2020

A phase 3 trial is expected to begin in 2021 and the company says that the compound could generate peak sales of more than a billion euros globally. At the beginning of this year, KaNDy completed a phase 2b trial of its first-in-class drug NT-814, showing activity against symptoms of the menopause such as hot flashes and night sweats.

Drugs 98

Drugs Hormones Marketing Trials 98

Pharmaceutical Technology

SEPTEMBER 8, 2022

Large medical and pharmaceutical companies are partnering with small compounding solution providers and research organisations and targeting major compounding pharmacies in regions such as the Asia Pacific to create a sustainable position in the compounding pharmacies market. Test method development.

Marketing 100

Marketing Pharmacy Containment Sales 100

XTalks

NOVEMBER 3, 2022

Mounjaro has thus taken off stronger than expected, surpassing Wall Street sales forecasts during the third quarter. Mounjaro was approved this summer as a Type 2 diabetes treatment and is the first diabetes drug with dual action, targeting two hormones involved in insulin production and appetite (GIP and GLP-1).

Sales 98

Sales FDA Approval Production Insulin 98

Pharmaceutical Technology

FEBRUARY 14, 2023

The company filed heterocyclic composition patents in areas such as PAD4 inhibitors, factor Xa inhibitors, and nuclear hormone receptor modulators. In terms of geographic reach, Bayer holds the top position, while Kangpu Biopharmaceuticals and German Cancer Research Center are in the second and third positions, respectively.

Antibody 130

Antibody Hormones DNA Licensing 130

XTalks

FEBRUARY 5, 2024

The top 40 best-selling oncology drugs in 2023, informed by 2022 sales statistics, mark significant milestones in cancer treatment and research. Read on to learn more about the top 40 best-selling oncology drugs in 2023, based on 2022 sales data. Price of Revlimid: A supply of 28 oral 2.5 mg capsules is $24,576.

FDA Approval 101

FDA Approval Drugs Sales Development 101

XTalks

JANUARY 23, 2024

Rare diseases, often overlooked in the broader medical research field, affect a small percentage of the population yet carry a significant burden for those diagnosed and their families. Pediatric growth hormone deficiency (PGHD) is one such condition, affecting a child’s growth and development.

Development 72

Development Hormones Drugs Trials 72

pharmaphorum

OCTOBER 11, 2020

Pfizer already makes big revenues from its breast cancer drug Ibrance, but a late-stage trial failure has set back its hopes of even loftier sales – and set up a challenge from Eli Lilly’s rival drug Verzenio. The post Ibrance trial failure dashes Pfizer’s growth hopes for the drug appeared first on.

Trials 52

Trials HR Hormones Drugs 52

The Pharma Data

MAY 14, 2021

Description: Acne No More is a clinically proven 5-step multi-dimensional clear skin system that has been polished and perfected over 13 years of research, trial, and error. CLICKBANK is a registered trademark of Click Sales, Inc., The website’s content and the product for sale. a Delaware. corporation located at 1444 S.

Production 52

Production Hormones Sales Licensing 52

XTalks

AUGUST 2, 2023

We delve into the driving forces behind their successes and shed light on the groundbreaking research that has earned them a place among the elite in the pharmaceutical arena. Most of the company’s revenue comes from the manufacture and sale of biopharmaceutical products. billion in pharmaceutical sales from 2021. billion, a 42.74

Sales 98

Sales Manufacturing FDA Approval Life Science 98

The Pharma Data

SEPTEMBER 29, 2021

Presentations will focus on Bayer’s ongoing focus in addressing patient needs through expanded research with existing therapies in certain cancers also as studies in new tumor types and together with other therapies. Research includes pain efficacy data in patients with mCRPC from the REASSURE and PARABO observational studies.

Research 52

Research Clinical Trials Clinical Trials Trials 52

The Pharma Data

MAY 13, 2021

But I’ve been a long time researcher passionate to help people all over the world on how to live better lives and spread awareness on how anyone can help support a healthy weight loss. Well, sleep keeps the “hunger hormones” (ghrelin and leptin) in check. Well, sleep keeps the “hunger hormones” (ghrelin and leptin) in check.

Hormones 52

Hormones Production Packaging Packaging 52

pharmaphorum

JULY 13, 2022

“Targeting CYP11A1 provides a compelling approach to suppressing the production of steroid hormones,” said Dean Li, president of Merck Research Laboratories. It is rumoured to be near to announcing a $40 billion takeover bid for the biotech.

Licensing 52

Licensing Licensing Hormones Production 52

The Pharma Data

APRIL 11, 2023

Bayer is progressing novel research around its prostate cancer treatment darolutamide. Both small molecule inhibitors in Immuno-Oncology are being jointly developed in a strategic research alliance with the German Cancer Research Center (DKFZ) in Heidelberg, Germany.

Research 40

Research Clinical Trials Clinical Trials Trials 40

XTalks

FEBRUARY 5, 2024

The top 40 best-selling oncology drugs in 2023, informed by 2022 sales statistics, mark significant milestones in cancer treatment and research. Read on to learn more about the top 40 best-selling oncology drugs in 2023, based on 2022 sales data. Price of Revlimid: A supply of 28 oral 2.5 mg capsules is $24,576.

FDA Approval 52

FDA Approval Drugs Sales Development 52

The Pharma Data

AUGUST 3, 2021

Product sales increased 3% globally, driven by double digit volume growth across a number of our products including Prolia ® (denosumab), Repatha ® (evolocumab) and our biosimilar products MVASI ® (bevacizumab-awwb) and KANJINTI ® (trastuzumab-anns). Product Sales Performance. Key results include: Total revenues increased 5% to $6.5

Sales 52

Sales Production Antibody Development 52

Delveinsight

DECEMBER 29, 2020

Relugolix is a once-daily, oral gonadotropin-release hormone (GnRH) receptor antagonist. billion – a deal that is split into upfront payments, and sales and regulatory milestone payments. To overcome this, Glucagon, a hormone in the body, helps the liver to quickly increase blood sugar levels. mg) in the US and Canada.

Trials 52

Trials Drugs Hormones Radiology 52

The Pharma Data

MARCH 11, 2021

The company is taking steps aimed at strengthening sales growth, profitability and free cash flow. We plan to continue to grow at Pharmaceuticals despite patent expirations and only expect to register a modest decline in sales in 2024,” he said. Speeding up sales growth. through 2023.

Sales 52

Sales Gene Therapy Marketing Gene 52

The Pharma Data

JUNE 19, 2023

For resistant breast cancers, two drugs may be better than one Cancer cells are even smarter than scientists previously believed, according to new CU Boulder research. The drugs have proven less toxic and more effective than previous treatments, propelling them to blockbuster status with billions of dollars in annual global sales.

Drugs 40

Drugs HR Scientist Hormones 40

pharmaphorum

AUGUST 16, 2022

. “Trodelvy is the cornerstone of our solid tumour portfolio,” commented Bill Grossman, Gilead’s head of oncology clinical research. “We look forward to rapidly advancing our development program in Asia and to realizing the clinical potential of Trodelvy across diverse tumour types.”

Licensing 52

Licensing Licensing Hormones Drugs 52

XTalks

NOVEMBER 9, 2023

Since its approval in May 2022, Mounjaro sales have hit $1.4 In the first half of 2023, sales of Ozempic and Wegovy rose by 58 percent and 363 percent, respectively. Zepbound contains mimetics of the GLP-1 and GIP hormones that regulate appetite and blood sugar. billion in just one year and a quarter. billion for Novo.

FDA Approval 59

FDA Approval Manufacturing Drugs Pharmacy 59

Delveinsight

DECEMBER 7, 2020

Unlike most other industries, in MedTech, AI is not confined to sales and operations ends of the value chain. The device can be configured to inject a specific dose of the hormones into the patient. The post Creating Future of MedTech Industry with Artificial Intelligence appeared first on DelveInsight Business Research.

Protein 56

Protein Insulin Development Hormones 56

The Pharma Data

MAY 15, 2021

SLIM OVER 55 is THE ONLY program for women over 55 that is especially designed for your body who has gone through menopause and needs to get all the hormones back in balance! We’re doing this sale to support your weight loss efforts during the COVID-19 PANDEMIC. You can get slim, healthy and fit even if you’re 70!

Production 52

Production Sales Hormones Vaccination 52

Roots Analysis

SEPTEMBER 9, 2024

Further, $400 billion is the anticipated sales of protein-based therapeutics in 2023. In addition, other industries, such as agriculture, cosmetics, food, environmental sciences, biomedical research and enzyme synthesis industry, are also benefiting from the protein expression process.

Protein 40

Protein Gene Production DNA 40

The Pharma Data

FEBRUARY 21, 2022

Bayer’s research and development pipeline continues to grow as the company is building on its existing competencies, such as the expertise around small molecules, while expanding into new modalities, including cell and gene therapies. “We In fiscal 2020, the Group employed around 100,000 people and had sales of 41.4 billion euros.

Radiology 52

Radiology Cardiology Development Production 52

Delveinsight

JANUARY 7, 2021

Omega Funds led the series B round with assists from fellow new investor Fidelity Management & Research and existing backers Atlas Venture, OrbiMed, and Bristol Myers Squibb, which became involved through its Celgene acquisition. The progress has set Ikena to raise USD 120 million. Ribometrix announces collaboration with Genentech.

RNA 52

RNA Clinical Trials Clinical Trials Bioavailability 52

The Pharma Data

AUGUST 30, 2021

“With deeper analyses in overall survival and quality of life in breast and prostate cancer, as well as exciting research in other solid tumors, our data at ESMO demonstrates our ambition to transform lives and renew patients’ hope for the future.”. Prostate Cancer. 177 Lu-PSMA-617. Abstract presentation # 647TiP. 16, 08:30 AM CEST.

HR 52

HR Production Trials Containment 52

The Pharma Data

MAY 16, 2021

It is well documented in the research literature that a contributing factor to Parkinson’s is exposure to toxins. When stress is relieved the body has an opportunity to bring all the hormones back into balance. CLICKBANK® is a registered trademark of Click Sales Inc., Toxic exposure may be closer to home than you realize.

Production 52

Production Hormones Sales Contamination 52

The Pharma Data

OCTOBER 26, 2020

Sales. COVID-19 Research Highlights. As monotherapy for the treatment of BRCA 1/2 metastatic castration-resistant prostate cancer (mCRPC) patients who have progressed following a prior therapy that included a new hormonal agent based on the Phase 3 PROfound trial. Total Sales.

Sales 40

Sales Vaccine Vaccination Production 40

pharmaphorum

APRIL 28, 2022

When a company, a big pharma company, calculates the financial impact, they also consider the sales force that they need, the marketing. Plus, many of these small players are very good at research, not necessarily at developing or commercialising their brands,” he said. So that is the trick.

Pharma Companies 59

Pharma Companies Branding Development Marketing 59

XTalks

MARCH 25, 2024

They work by mimicking the action of the naturally occurring hormone GLP-1, which is involved in regulating blood sugar and appetite. In a controversial decision, the medication’s use was expanded to adolescents, which is a concern since research suggests the drugs must be taken for life in order to maintain results.

Drugs 105

Drugs Medicine Life Science Production 105

The Pharma Data

JANUARY 10, 2021

We expect to further advance our late stage endocrinology pipeline with the anticipated approval and launch in the United States and the approval in Europe of TransCon hGH for pediatric growth hormone deficiency, and to obtain phase 3 results for TransCon PTH in adult hypoparathyroidism. •. ?. .

Hormones 40

Hormones Clinical Development Clinical Trials Clinical Trials 40

The Pharma Data

SEPTEMBER 16, 2020

Data will also be presented for two of our investigational hormone receptor (HR)-positive breast cancer treatments, both of which target the PI3K/AKT signalling pathway, a key driver of cancer cell growth and proliferation. billion in R&D and posted sales of CHF 61.5 GDC-0077 is our next generation investigational PI3K?

HR 52

HR Medicine Hormones Trials 52